Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amy E Boles"'
Autor:
Colleen Isabelle, Kathleen McConnell, Amy E Boles, Jonathan E Brammer, Robyn Berge, Carla Portocarrero, Nitin Chakravarti, Pierluigi Porcu, Neda Nikbakht, Anjali Mishra
Publikováno v:
Blood. 140:9216-9218
Autor:
Aharon G. Freud, Anjali Mishra, Monique Mathé-Allainmat, Amy E Boles, Pierluigi Porcu, Agnès Quéméner, Anthony Mansour, Jonathan E. Brammer, Erwan Mortier
Publikováno v:
61th ASH Annual Meeting
61th ASH Annual Meeting, Dec 2019, Orlando, Florida, United States. pp.3776-3776, ⟨10.1182/blood-2019-131174⟩
61th ASH Annual Meeting, Dec 2019, Orlando, Florida, United States. pp.3776-3776, ⟨10.1182/blood-2019-131174⟩
Background and Rationale: T-cell large granular lymphocytic leukemia (T-LGLL) is an incurable clonal proliferation of CD8+ memory T-cells that leads to profound neutropenia and anemia with limited treatment options. The primary driver of T-LGLL is ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131f4b3e01e4e13241cac3f969319a89
https://www.hal.inserm.fr/inserm-02991752
https://www.hal.inserm.fr/inserm-02991752
Autor:
Robyn Berge, Jonathan E. Brammer, Ashley N. Vogel, Liam Nisenfeld, Kathleen McConnell, Guldeep Uppal, William T. Johnson, Nitin Chakravarti, Amy E Boles, Jerald Z. Gong, Colleen Isabelle, Pierluigi Porcu, Anjali Mishra
Publikováno v:
Blood. 138:2408-2408
Introduction: Mature T-cell neoplasms (MTCN) are a heterogeneous and aggressive group of lymphoid neoplasms with very limited options for precision immunotherapy. Targeted immunotherapy with antibodies directed against surface markers on tumor cells
Autor:
Anjali Mishra, Monique Mathé-Allainmat, Amy E Boles, Jonathan E. Brammer, Agnès Quéméner, Anthony Mansour, Pierluigi Porcu
Publikováno v:
Journal of Clinical and Translational Science. 5:92-92
IMPACT: This work describes, for the first time, the methylome in patients with T-LGLL, focusing on the IL-15 promoter, and clearly demonstrates that 5-azacytidine decreases IL-15 production leading to T-LGLL cell death. These results form the basis
Autor:
Colleen Isabelle, Zhiyao Li, Logan A. Chrislip, David Clever, Anthony Mansour, Kathleen McConnell, Amy E Boles, Anjali Mishra, Michael A. Caligiuri
Publikováno v:
Blood. 136:37-37
The role of microRNA (miR) is rapidly advancing with numerous functions discovered in cancer pathogenesis. We had previously shown a significant decrease in miR-29b levels in malignant cells isolated from peripheral blood of cutaneous T-cell lymphoma